Alembic Limited announced that at the 116th Annual General Meeting of the Company held on August 10, 2023 approved to appoint Dr. Girish Hirode (DIN:10145777) as an Independent Director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.89 INR | -0.33% | +1.99% | +3.62% |
Apr. 18 | Alembic Pharmaceuticals Board to Consider Dividend for Fiscal 2024; Shares Drop 3% | MT |
Apr. 02 | Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment | MT |
1st Jan change | Capi. | |
---|---|---|
+3.62% | 290M | |
+40.28% | 27.94B | |
-13.03% | 26.97B | |
+21.99% | 26.95B | |
+1.61% | 25.32B | |
+49.49% | 22.58B | |
+2.78% | 19.59B | |
+4.80% | 19.52B | |
+30.40% | 16.23B | |
-14.03% | 14.98B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- News Alembic Limited
- Alembic Limited Appoints Dr. Girish Hirode as an Independent Director of the Company